おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
PegBio
company
About
PegBio is a Chinese innovative drug developer.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥7M
- Industries
- Health Care,Pharmaceutical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Founded in 2008, Suzhou city-based PegBio is a bio-pharmaceutical company specializing in the development of innovative drugs to combat diabetes and obesity. Its key product PB-119, an agonist of glucagon-like peptide 1 (GLP-1), allows diabetes patients to take medicine once a week, instead of requiring daily injections.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥7M
PegBio has raised a total of
¥7M
in funding over 2 rounds. Their latest funding was raised on
Oct 15, 2015 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 15, 2015 | Series C | ¥7M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
PegBio is funded by 1 investors.
Mingxin China Growth Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Mingxin China Growth Fund
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
